Clinical Trials Browser

Recruiting × Head and Neck Neoplasms × tislelizumab × Clear all

NCT05758389 2025-09-05

Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

Phase 2 Recruiting

Head and Neck Neoplasms

NCT05595590 2022-10-27

Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer

Phase 2 Recruiting

Head and Neck Neoplasms